Endometrial effects of intrauterine levonorgestrel

被引:97
作者
Guttinger, Anja [1 ]
Critchley, Hilary O. D. [1 ]
机构
[1] Univ Edinburgh, Div Reprod & Dev Sci, Queens Med Res Inst, Ctr Reprod Biol, Edinburgh EH16 4TJ, Midlothian, Scotland
关键词
endometrium; LNG-IUS; breakthrough bleeding; steroid receptors;
D O I
10.1016/j.contraception.2007.01.015
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Local intrauterine delivery of levonorgestrel (LNG) results in extensive decidualization of endometrial stromal cells, atrophy of the glandular and surface epithelium and changes in vascular morphology (suppression of spiral artery formation and presence of large dilated vessels). With endometrial exposure to LNG, there is down-regulation of sex steroid receptors in all cellular components. As a consequence of endometrial sex steroid receptor down-regulation, there is perturbation of progesterone-regulated locally acting mediators, and the integrity of blood vessel walls is disturbed. Thus, intrauterine LNG administration results in modulation of local mediators regulating endometrial function. To date, no single factor has been identified where the expression correlates closely with unscheduled breakthrough bleeding (BTB). BTB is a common side effect and reason for discontinuation of LNG-IUS use. Much remains to be determined about the mechanisms involved in suppression of menstruation, BTB episodes and the local endometrial environment with local LNG administration. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:S93 / S98
页数:6
相关论文
共 53 条
[41]   Matrix metalloproteinases in normal menstruation [J].
Salamonsen, LA ;
Woolley, DE .
HUMAN REPRODUCTION, 1996, 11 :124-133
[42]   Regulation of matrix metalloproteinases in human endometrium [J].
Salamonsen, LA ;
Zhang, J ;
Hampton, A ;
Lathbury, L .
HUMAN REPRODUCTION, 2000, 15 :112-119
[43]  
SCARSELLI G, 1988, European Journal of Gynaecological Oncology, V9, P284
[44]   LONG-TERM CONTRACEPTION WITH THE LEVONORGESTREL 20 MCG/DAY (LNG 20) AND THE COPPER-T 380AG INTRAUTERINE-DEVICES - A 5-YEAR RANDOMIZED STUDY [J].
SIVIN, I ;
ELMAHGOUB, S ;
MCCARTHY, T ;
MISHELL, DR ;
SHOUPE, D ;
ALVAREZ, F ;
BRACHE, V ;
JIMENEZ, E ;
DIAZ, J ;
FAUNDES, A ;
DIAZ, MM ;
COUTINHO, E ;
MATTOS, CER ;
DIAZ, S ;
PAVEZ, M ;
STERN, J .
CONTRACEPTION, 1990, 42 (04) :361-378
[45]   Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel [J].
Skinner, JL ;
Riley, SC ;
Gebbie, AE ;
Glasier, AF ;
Critchley, HOD .
HUMAN REPRODUCTION, 1999, 14 (03) :793-799
[46]  
SMITH OPM, 2005, ANGIOGENESIS, V7, P1
[47]   Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: A dose-response study by the Gynecologic Oncology Group [J].
Thigpen, JT ;
Brady, MF ;
Alvarez, RD ;
Adelson, MD ;
Homesley, HD ;
Manetta, A ;
Soper, JT ;
Given, FT .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) :1736-1744
[48]   Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS) - A systematic enquiry and overview [J].
Varma, Rajesh ;
Sinha, Deepali ;
Gupta, Janesh K. .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2006, 125 (01) :9-28
[49]   Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate:: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding? [J].
Vincent, AJ ;
Zhang, J ;
Östör, A ;
Rogers, PAW ;
Affandi, B ;
Kovacs, G ;
Salamonsen, LA .
HUMAN REPRODUCTION, 2002, 17 (05) :1189-1198
[50]   Endometrial breakdown in women using Norplant is associated with migratory cells expressing matrix metalloproteinase-9 (gelatinase B) [J].
Vincent, AJ ;
Malakooti, N ;
Zhang, J ;
Rogers, PAW ;
Affandi, B ;
Salamonsen, LA .
HUMAN REPRODUCTION, 1999, 14 (03) :807-815